Companies & Industry »Company News»Company News Details
Company News Details

BSE   25 May 18 | 12:00 AM

998.00 21.8 (2.23%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532331
Face Value: N.A.

NSE   25 May 18 | 12:00 AM

998.05 20.45 (2.09%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: AJANTPHARM
Performance
1 Week : Rs 1,023.55 (-2.50%)
1 Month : Rs 1,364.30 (-26.85%)
1 Year : Rs 1,596.65 (-37.49%)
change companytradenow
Back

Ajanta Pharma gains on USFDA nod for Almotriptan Malate tablets

SI Reporter / Mumbai 08 Mar 16 | 10:00 AM

Shares of Ajanta Pharma were up nearly 3% at Rs 1,435 after the company said it has received final approval of Almotriptan Malate tablets in dosages of 6.25mg and 12.5mg.

The tablets are the generic version of Axert which are dispensed for the treatment of acute migraine pain relief. Ajanta Pharma USA Inc., a wholly-owned subsidiary of Ajanta Pharma Ltd, is scheduled to launch Almotriptan tables in US shortly, the company said in a release.

Widgets Magazine

Till date, USFDA has granted Ajanta Pharma eight ANDA final approvals and two tentative approvals, the release added.

The stock opened at Rs 1,421 and touched a high of Rs 1,449. At 10am, over 74,000 shares were traded on both the stock exchanges.

Widgets Magazine

Sensex

Company Price Gain (%)
O N G C175.354.59
Tata Steel567.203.43
Yes Bank339.452.71
Adani Ports379.902.34
IndusInd Bank1,914.752.33

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine